Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5356-5363
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5356
Table 5 Isoflavone intake levels in groups of ulcerative colitis individuals declaring lack of tenesmus and declaring presence of tenesmus (comparison conducted using U Mann-Whitney test)
Individuals declaring lack of constipations(n = 47)
Individuals declaring constipations(n = 9)
P value
Mean ± SDMedian (min-max)Mean ± SDMedian (min-max)
Intake
Daidzein (μg)124.5 ± 107.8101.01 (3.3-476.7)249.4 ± 284.4205.71 (5.3-977.7)0.0818
Genistein (μg)190.4 ± 233.0138.01 (2.3-1428.3)110.0 ± 79.7126.0 (7.3-253.7)0.3662
Glycitein (μg)2.3 ± 9.60.01 (0.0-56.0)0.0 ± 0.00.01 (0.0-0.0)0.3819
Total isoflavones (μg)317.2 ± 280.2302.31 (18.0-1574.0)359.4 ± 311.7242.31 (139.3-1137.7)0.7379
Intake per 1000 kcal
Daidzein (μg/1000 kcal)70.6 ± 76.748.11 (1.3-347.7)117.2 ± 111.695.11 (4.5-392.7)0.0943
Genistein (μg/1000 kcal)101.4 ± 130.769.11 (1.4-759.2)55.7 ± 42.546.5 (3.6-117.4)0.3722
Glycitein (μg/1000 kcal)1.4 ± 6.10.01 (0.0-37.4)0.0 ± 0.00.01 (0.0-0.0)0.3819
Total isoflavones (μg/1000 kcal)173.4 ± 171.7131.21 (8.3-836.7)173.0 ± 113.5140.91 (73.4-456.9)0.5770